Document is current
Any future updates will be listed below
-
Authors
Bolini, Lukas
Habib, Joyce G.
Galluzzi, Lorenzo
- License Information
-
More Information
Article History
Received: 7 August 2025
Accepted: 3 September 2025
First Online: 16 October 2025
Competing interests
: L.G. is/has been holding research contracts with Lytix Biopharma, Promontory and Onxeo, has received consulting/advisory honoraria from Boehringer Ingelheim, AstraZeneca, AbbVie, OmniSEQ, Onxeo, The Longevity Labs, Inzen, Imvax, Sotio, Promontory, Noxopharm, EduCom, and the Luke Heller TECPR2 Foundation, and holds Promontory stock options. L.B. and J.G.H. have no conflicts of interest to declare.
